2024-10-20 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis

**1. Performance Comparison:**

CVS Health Corp (CVS) has underperformed significantly compared to the S&P 500 (VOO). As of today, CVS has a cumulative return of **-34.25%** while VOO has returned **137.88%**. This puts CVS at a **-172.13%**  deficit relative to the S&P 500. This signifies that CVS's performance has been drastically worse than the broader market, placing it at the bottom 0% percentile of historical performance compared to the benchmark. 

**2. Recent Price Movements:**

* **Closing Price:** 60.34
* **5-Day Moving Average:** 64.3
* **20-Day Moving Average:** 63.07
* **60-Day Moving Average:** 59.76

The stock is currently trading below its 5-day, 20-day, and 60-day moving averages, indicating potential downward momentum.

**3. Technical Indicators:**

* **RSI:** 41.68 - This suggests that the stock is in oversold territory, indicating potential for a rebound.
* **PPO:** -0.68 - A negative PPO indicates a weakening trend, suggesting potential for further price declines.
* **Delta_Previous_Relative_Divergence:** -0.11 - This indicates that CVS's recent performance has lagged behind the S&P 500, suggesting short-term downward pressure.
* **Expected_Return:** 0.0% -  This implies that CVS is not expected to outperform the S&P 500 in the long term.

**4. Recent Earnings and Outlook:**

| Date       | EPS | Expected EPS |
|------------|-----|--------------|
| 2024-08-07 | 1.83 | 1.73         |
| 2024-05-01 | 1.31 | 1.70         |
| 2024-02-07 | 2.12 | 2.01         |
| 2023-11-01 | 2.21 | 2.13         |
| 2023-08-02 | 2.21 | 2.12         |

CVS's latest earnings report showed EPS of 1.83, exceeding the expected EPS of 1.73. This suggests that the company might be performing better than anticipated. However, the overall trend for the past few quarters shows that CVS has consistently fallen short of analysts' EPS estimates. This could indicate potential for future underperformance.

**5. News and Recent Issues:**

* **Recent Market Outlook for CVS:** CVS is a defensive stock that is often sought after by investors seeking stability and consistent dividend income. However, the company's recent performance has been lackluster, which could be attributed to factors such as increased competition and pricing pressures.
* **Analyst Opinions:** Despite the recent underperformance, some analysts remain bullish on CVS's long-term prospects. They point to the company's strong brand recognition, diversified business model, and commitment to innovation. However, others are more cautious, citing concerns about the company's growth potential.
* **Performance Highlights:** CVS's stock price has been relatively volatile in recent months, experiencing sharp drops followed by periods of consolidation. The company has faced several challenges, including increased competition from online retailers and the rising costs of prescription drugs. However, CVS is also investing in growth initiatives, such as expanding its pharmacy network and developing new healthcare services.

**6. Overall Analysis:**

CVS Health Corp is currently facing a period of underperformance, significantly lagging behind the S&P 500. Its recent earnings have exceeded expectations, but the consistent trend of missing analysts' EPS estimates raises concerns about its future performance.  While technical indicators suggest potential for a rebound, the stock is currently in a bearish trend. Investors considering CVS need to weigh the potential benefits of its defensive nature and dividend income against the current underperformance and the uncertain future outlook.

**7. Recommendation:**

Given the current situation, CVS might not be a suitable choice for investors seeking aggressive growth. It might be better suited for investors with a longer-term perspective, who can stomach some volatility and are comfortable with a lower-growth investment.  However, a thorough examination of the company's future strategy and ability to overcome existing challenges is recommended before any investment decision is made. 
